Preserve study integrity. Resist the temptation to bolt new exploratory endpoints midstream. If an additional endpoint is ...
The Board on Environmental Studies and Toxicology was formed in February 1986 from the merger of the Board on Toxicology and Environmental Health Hazards (est. 1977) and the Environmental Studies ...
Phyto-N 28-Day Repeat-Dose Study in Rats and Dogs Shows No Findings of Toxicological Significance at Maximum Feasible Dose, Enabling Advancement to GLP Toxicology Program Jericho, New York, March 18, ...
In 2013, fasiglifam, a promising diabetes drug candidate, was withdrawn from late-stage clinical trials by its developer, following signs of liver damage in the trial participants. Like all drugs ...
– SL-325 is a high-affinity DR3 blocking antibody being developed for the treatment of inflammatory bowel disease (IBD); No evidence of toxicity or residual agonism observed in non-human primate ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule ...
PsyPost on MSN
Bladder toxicity risk appears low for psychiatric ketamine patients, though data is limited
A new review of clinical studies suggests that people receiving ketamine for mental health conditions do not face an elevated ...
Evecxia Therapeutics Reports No Toxicology Findings in Nonclinical GLP Studies of Adjunctive EVX-101
- Oral EVX-101 administration over 3 months was modeled in rats and pigs co-treated with the first-line antidepressant fluoxetine. - There were no toxicological findings in either species, even at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results